Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1200/JCO.2015.62.8883 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Developing a Machine Learning-Based Automated Patient Engagement Estimator for Telehealth: Algorithm Development and Validation Study.
JMIR Form Res
January 2025
Department of Computer Science, Purdue University, West Lafayett, IN, United States.
Background: Patient engagement is a critical but challenging public health priority in behavioral health care. During telehealth sessions, health care providers need to rely predominantly on verbal strategies rather than typical nonverbal cues to effectively engage patients. Hence, the typical patient engagement behaviors are now different, and health care provider training on telehealth patient engagement is unavailable or quite limited.
View Article and Find Full Text PDFA discriminative multi-modal adaptation neural network model for video action recognition.
Neural Netw
January 2025
Department of Electrical, Computer and Biomedical Engineering, Toronto Metropolitan University, Toronto, Canada.
Research on video-based understanding and learning has attracted widespread interest and has been adopted in various real applications, such as e-healthcare, action recognition, affective computing, to name a few. Amongst them, video-based action recognition is one of the most representative examples. With the advancement of multi-sensory technology, action recognition using multi-modal data has recently drawn wide attention.
View Article and Find Full Text PDFThe time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force.
Eur Psychiatry
January 2025
Dutch Clozapine Collaboration Group, Alkmaar, The Netherlands.
The European Clozapine Task Force is a group of psychiatrists and pharmacologists practicing in 18 countries under European Medicines Agency (EMA) regulation, who are deeply concerned about the underuse of clozapine in European countries. Although clozapine is the most effective antipsychotic for people with treatment-resistant schizophrenia, a large proportion of them do not have access to this treatment. Concerns about clozapine-induced agranulocytosis and stringent blood monitoring rules are major barriers to clozapine prescribing and use.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!